JO
KURA icon

John Overdeck’s Kura Oncology KURA Stock Holding History

John Overdeck’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Sell
167,581
-190,374
-53% -$1.8M ﹤0.01% 3067
2026
Q1 		$2.91M Sell
357,955
-113,839
-24% -$978K ﹤0.01% 2464
2025
Q4 		$4.9M Buy
471,794
+267,069
+130% +$2.8M 0.01% 1739
2025
Q3 		$1.81M Sell
204,725
-105,513
-34% -$752K ﹤0.01% 2197
2025
Q2 		$1.79M Buy
310,238
+151,251
+95% +$927K ﹤0.01% 1919
2025
Q1 		$1.05M Sell
158,987
-7,132
-4% -$55.6K ﹤0.01% 2149
2024
Q4 		$1.45M Sell
166,119
-42,120
-20% -$606K ﹤0.01% 1939
2024
Q3 		$4.07M Sell
208,239
-64,035
-24% -$1.3M 0.01% 1178
2024
Q2 		$5.61M Buy
272,274
+94,624
+53% +$1.95M 0.01% 957
2024
Q1 		$3.79M Buy
+177,650
New +$3.45M 0.01% 1119
2022
Q4 		– Sell
-255,139
Closed -$3.48M – 2947
2022
Q3 		$3.48M Buy
255,139
+163,239
+178% +$2.52M 0.01% 900
2022
Q2 		$1.69M Sell
91,900
-54,373
-37% -$782K 0.01% 1282
2022
Q1 		$2.35M Sell
146,273
-356,554
-71% -$5.15M 0.01% 1279
2021
Q4 		$7.04M Buy
502,827
+88,672
+21% +$1.44M 0.02% 1002
2021
Q3 		$7.76M Sell
414,155
-372,272
-47% -$7.01M 0.02% 904
2021
Q2 		$16.4M Buy
786,427
+178,144
+29% +$4.42M 0.04% 576
2021
Q1 		$17.2M Buy
608,283
+24,367
+4% +$771K 0.04% 496
2020
Q4 		$19.1M Buy
583,916
+568,716
+3,742% +$20M 0.05% 390
2020
Q3 		$466K Sell
15,200
-118,312
-89% -$2.61M ﹤0.01% 2299
2020
Q2 		$2.18M Sell
133,512
-32,258
-19% -$465K 0.01% 1055
2020
Q1 		$1.65M Sell
165,770
-14,653
-8% -$168K 0.01% 1078
2019
Q4 		$2.48M Buy
180,423
+116,777
+183% +$1.73M 0.01% 1421
2019
Q3 		$966K Sell
63,646
-23,256
-27% -$414K ﹤0.01% 2022
2019
Q2 		$1.71M Buy
86,902
+18,727
+27% +$311K 0.01% 1545
2019
Q1 		$1.13M Buy
+68,175
New +$1.05M ﹤0.01% 1747
2018
Q4 		– Sell
-19,027
Closed -$333K – 3283
2018
Q3 		$333K Buy
+19,027
New +$365K ﹤0.01% 2704
2018
Q2 		– Sell
-38,744
Closed -$726K – 3491
2018
Q1 		$726K Buy
+38,744
New +$754K ﹤0.01% 2225

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

John Overdeck's KURA Position: Q2 2026 in Review

John Overdeck reduced its Kura Oncology (KURA) stake by 53% in Q2 2026, selling an estimated $1.8M and leaving 167,581 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

John Overdeck first reported a position in KURA in Q1 2018 and has held it in 27 quarters since. The position peaked at $19.1M in Q4 2020. 219 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • John Overdeck held 167,581 shares of Kura Oncology worth $1.84M as of Q2 2026.
  • John Overdeck sold 190,374 Kura Oncology shares in Q2 2026, an estimated $1.8M.
  • Kura Oncology made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3067 holding.
  • John Overdeck first reported a position in Kura Oncology in Q1 2018 and has held it in 27 quarters since.
  • John Overdeck's Kura Oncology position peaked at $19.1M in Q4 2020.
  • 219 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.